##Investigating some gemcitibine related genes
#DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells.deoxycytidine kinase (DCK). DCK is a key enzyme that activates gemcitabine by phosphorylation
#so does DCK fcexpression correlate with drugsensitivity

library(basicTrendline)

colnames(fcgeneexpression)=metadata[1:819,3]
fc_DCK <- fcgeneexpression["DCK",]

palette(rainbow(15))
drugnames <- metadata$drug
levels=as.factor(levels(drugnames))
plot(fc_DCK, col = metadata[1:819,3], main = "fold change of DCK", xlab = "samples", ylab = "fold change of DCK")
legend("right", inset=c(-0.25,0),legend=levels(drugnames), pch=20, col = levels, xpd =TRUE, title = "drugs")

fc_DCK_gemci <- fc_DCK[365:420]

drugsensitivity_gemci <- drugsensitivity["gemcitibine",]
d <- rbind(drugsensitivity_gemci, fc_DCK_gemci)

d_no_nas <- d[,-c(29,18)]

fc_of_DCK_gemci <- as.vector(d_no_nas[2,])

sensitivity <- as.vector(d_no_nas[1,])

trendline(fc_of_DCK_gemci, sensitivity)


#differentially expressed in gemcitabine-sensitive cancers: microsomal glutathione S-transferase 1 (GSTT1), topoisomerase II alpha (TOP2A), caspase 3, and ATP-binding cassette and subfamily C member 2 (ABCC2)

library(basicTrendline)
colnames(fcgeneexpression)=metadata[1:819,3]

#same for TOP2A and ABCC2
fc_TOP2A <- fcgeneexpression["TOP2A",]
fc_ABCC2 <- fcgeneexpression["ABCC2",]
fc_GSTT1 <- fcgeneexpression["GSTT1",]

plot(fc_TOP2A, col = metadata[1:819,3])
plot(fc_ABCC2, col = metadata[1:819,3])
plot(fc_GSTT1, col = metadata[1:819,3])

fc_TOP2A_gemci <- fc_TOP2A[365:420]
fc_ABCC2_gemci <- fc_ABCC2[365:420]
fc_GSTT1_gemci <- fc_GSTT1[365:420]

drugsensitivity_gemci <- drugsensitivity["gemcitibine",]
a <- rbind(drugsensitivity_gemci, fc_TOP2A_gemci)
b <- rbind(drugsensitivity_gemci,fc_ABCC2_gemci)
c <- rbind(drugsensitivity_gemci,fc_GSTT1_gemci)

a_no_nas <- a[,-c(29,18)]
b_no_nas <- b[,-c(29,18)]
c_no_nas <- c[,-c(29,18)]

fc_of_TOP2A_gemci <- as.vector(a_no_nas[2,])
fc_of_ABCC2_gemci <- as.vector(b_no_nas[2,])
fc_of_GSTT1_gemci <- as.vector(c_no_nas[2,])

sensitivity <- as.vector(a_no_nas[1,])


trendline(fc_of_TOP2A_gemci, sensitivity)
trendline(fc_of_ABCC2_gemci, sensitivity)
trendline(fc_of_GSTT1_gemci, sensitivity)

#as you can see there is no visible linear relation between the expression of CMPK or DCK and drugsensitivity, you can also see 
that gemcitibine treatment leads to a higher expression of DCK compared to the other drugs.
 differentially expressed in gemcitabine-sensitive cancers: microsomal glutathione S-transferase 1 (GSTT1), 
 topoisomerase II alpha (TOP2A), caspase 3, and ATP-binding cassette and subfamily C member 2 (ABCC2)
 or: SLC29A2, SLC281A
